Stay updated on Pembrolizumab Combos in mCRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.

Latest updates to the Pembrolizumab Combos in mCRC Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays the completed KEYNOTE-651 study record, including its treatment arms, eligibility criteria, study locations, outcome measures, publications, and supporting documents, instead of a forbidden-error message.SummaryDifference98%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedAn NIH-wide notice about a terminology transition appears at the top of the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content and blocking access to the NCT03374254 details.SummaryDifference23%

- Check57 days agoChange DetectedThe study page now shows a newer revision tag (v3.7.0), indicating the page was updated to the latest version.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combos in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.